481 Results (Page 11 of 20)
Spain Markets Research Reports
Spain Proliferative Diabetic Retinopathy Market Analysis
Spain Proliferative Diabetic Retinopathy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Proliferative Diabetic Retinopathy market is growing globally due to the increase in geriatric population, increase in the prevalence of diabetes and diabetic retinopathy, technological advancements in diagnosis and treatment of proliferative diabetic retinopathy, increasing awareness about the disease, growing healthcare expenditure, increase in research and development, government initiatives like supporting policies and reimbursement schemes. Bayer, Allergan, Novartis, Oxurion, Sirnaomics, Genentech, Alimera Sciences, Ampio Pharmaceuticals, BCN Peptides and Kowa Company Ltd. are the key global market players in Proliferative Diabetic Retinopathy Market.
Spain Prostate Cancer Drugs Market Analysis
Spain Prostate Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Prostate Cancer Drugs market is growing globally due to the increasing incidence and prevalence of prostate cancer in men globally, aging population, technological advancements in diagnostics improvements in imaging techniques like multiparametric magnetic resonance imaging (mpMRI), prostate-specific antigen (PSA) tests, and the development of new biomarkers, growing awareness about the disease, improvements in healthcare expenditure and emergence of strong pipeline drugs. Johnson & Johnson Private Limited, Astellas Pharma Inc., Ipsen Pharma, Sanofi, Bayer AG, AbbVie Inc., AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott, Takeda Pharmaceutical Company Limited., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Myovant Sciences GmbH, Tolmar Pharmaceuticals, Inc., Ferring B.V., Dendreon Pharmaceuticals LLC. and Genentech, Inc. are the key global market players in prostate cancer drugs market.
Spain Psoriasis Drugs Market Analysis
Spain Psoriasis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Psoriasis Drugs market is growing globally due to the rise in the prevalence of chronic diseases globally, growing awareness and diagnosis about the disease, advancements in biologic therapies like TNF inhibitors, IL-17 inhibitors and IL-23 inhibitors, pipeline development including small molecules and biologics, patient support programs and patient advocacy groups, increase in collaborations among pharmaceutical companies and research organizations, surge in government initiatives and development in technology. Eli Lilly & Company, Pfizer Inc., Janssen Global Services LLC, Celgene Corporation, Takeda Pharmaceutical Company Limited, Novartis International AG, Amgen Inc., Biogen Inc., Abbvie Inc., AstraZeneca, Boeringer Ingelheim International GmbH, Biogen, Johnson & Johnson Services Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd., Stiefel Laboratories, UCB S.A., LEO Pharma, Cipla Inc., Rowan Bioceuticals, Glenmark Pharmaceuticals, and Win-Medicare Pvt. Ltd., are the key global market players in psoriasis drug market.
Spain Pulmonary Arterial Hypertension Drugs Market Analysis
Spain Pulmonary Arterial Hypertension Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pulmonary Arterial Hypertension Drugs market is growing globally due to the increasing rates of respiratory and cardiovascular diseases, as well as an ageing population. A change in lifestyle, such as excessive alcohol use, a lack of exercise, and unhealthy eating habits, has increased the risk of hypertension and high blood pressure, increasing prevalence of PAH, advancements in drug therapies, advancements in research and development, growing patient awareness leading to early diagnosis and treatment initiation, support from regulatory authorities, increasing healthcare expenditure and collaborations between pharmaceutical companies. GlaxoSmithKline PLC., Teva Pharmaceuticals Industries Ltd., Actelion Pharmaceuticals US, Inc., United Therapeutics Corp., Sandoz AG, Dr. Reddy's Laboratories Ltd, Par Pharmaceutical., Natco Pharma Ltd., Zydus Pharmaceutical USA., Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Mylan N.V., Sigmapharm Laboratories, LLC., Gilead Sciences, Inc., Pfizer Inc., Amneal Pharmaceutical Inc. are the key global market players in pulmonary arterial hypertension drugs market.
Spain Rabies Vaccine Market Analysis
Spain Rabies Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rabies Vaccine market is growing globally due to the rising incidence of rabies, government initiatives and vaccination programs, growing pet ownership and animal healthcare realizing the importance of vaccination, technological advancements leading to more safe and effective vaccines, collaborations and partnerships between vaccine manufacturers and government bodies. Serum Institute of India Pvt. Ltd, Novartis AG, Cadila Pharmaceuticals, and Merck & Co., Inc., Sanofi, ADS Diagnostic Ltd, GSK plc, Berna Biotech Pharma GmbH, and AstraZeneca are the key global market players in rabies vaccine market.
Spain Remicade Biosimilar Market Analysis
Spain Remicade Biosimilar Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Remicade Biosimilar market is growing globally due to the rising prevalence of autoimmune illnesses including rheumatoid arthritis, plaque psoriasis, introduction of a biosimilar version could provide financial relief for healthcare systems and increased access to essential medication for patients, quicker intravenous administration reaction times, patent expiry of branded versions will create opportunity biosimilars over other branded counterparts, thus increasing remicade biosimilar demand, growing awareness about its long-term benefits and better reimbursement scenario, technological advancements in the field of biosimilars, an increase in R&D spending by pharmaceutical companies and growing awareness about biosimilars among healthcare professionals and patients. Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku are some major players in the global Remicade (infliximab mAb) market.
Spain Anemia Therapeutics Market Analysis
The Spain Anemia Therapeutics Market is anticipated to experience a growth from $286 Mn in 2022 to $533 Mn by 2030, with a CAGR of 8.1 % during the forecast period of 2022-2030. The Spain Anemia Therapeutics Market encompasses various players across different segments, including Amgen, AbbVie, Roche, Pfizer, AstraZeneca, Merck & Co., Arafarma Group, Rolabo Outsourcing, Elli Lily, Persan Pharma etc, among various others.
Spain Cardiovascular Drugs Market Analysis
Spain Cardiovascular Drug Market is at around $2.67 Bn in 2022 and is projected to reach $3.30 Bn in 2030, exhibiting a CAGR of 2.8% during the forecast period. Major reasons propelling the growth of this market are the increasing prevalence of chronic diseases and technological advancements. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
Spain Dermatological Therapeutics Market Analysis
Spain Dermatological Therapeutics Market is at around $0.78 Bn in 2023 and is projected to reach $1.31 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is expanding due to factors such as trends in cosmetic dermatology, healthcare infrastructure and access to dermatological care, and advancements in dermatology technology. The market is dominated by key players like Skin Tech Pharma, Grupo Juste, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.
Spain Alopecia (Hair Loss) Therapeutics Market Analysis
The Spain Alopecia (Hair Loss) Therapeutics Market was valued at US $158 Mn in 2022, and is predicted to grow at (CAGR) of 6.5% from 2023 to 2030, to US $262 Mn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, technological advancements, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Cipla, Sun Pharmaceuticals, Allergan, and Pfizer, among others.
Spain Digital Therapeutics Market Analysis
Spain Digital Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.61 Bn in 2030, exhibiting a CAGR of 26.2% during the forecast period. Growing Chronic diseases, government initiatives, and technological developments are propelling the growth of the market. The market is dominated by key players like Medtep, Nubentos, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Spain Allergy Therapeutics Market Analysis
Spain Allergy Therapeutics Market was valued at $448 Mn in 2022 and is estimated to reach $682 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim, and Allergan.
Spain Alcohol Addiction Therapeutics Market Analysis
The Spain Alcohol Addiction Therapeutics Market is valued at around $14 Mn in 2022 and is projected to reach $21 Mn by 2030, exhibiting a CAGR of 5.3% during the forecast period. The primary growth drivers of the Spain alcohol addiction therapeutics market are government-supported initiatives promoting addiction treatment and harm reduction, as well as an increasing prevalence of alcohol use, demographic trends, and the incorporation of innovative technologies to improve accessibility and flexibility in treatment approaches. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Spain are Elli Lily, Roche, AbbVie, Lundbeck, Alkermes, Otsuka Pharmaceuticals, Janssen, Kern Pharma, Ferrer, Esteve etc among others
Spain Age-Related Macular Degeneration Therapeutics Market Analysis
The Spain Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $208 Mn in 2022 and is predicted to grow at a CAGR of 7.90% from 2023 to 2030, to US $383 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in treatment, and other factors. Major players in the industry include Regeneron Pharmaceuticals, Novartis, Bayer, Roche, Genentech, and other notable companies
Spain Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Spain Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $64 Mn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $108 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, rising demand and unmet needs, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Grifols, AB-Biotics, Roche, Sanofi, Pfizer Inc, among other players.
Spain Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Spain Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $21 Mn in 2022, and is predicted to grow at (CAGR) of 4.8% from 2023 to 2030, to US $31 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, strong healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Pfizer, Palladio, Reata, Xortx, Janssen among others
Spain Addiction Therapeutics Market Analysis
Spain addiction therapeutics market was valued at $195 Mn in 2022 and is estimated to reach $308 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatment is growing as a result of the growing understanding and recognition of substance use disorders as serious public health issues. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceutical Industries, Mundipharma, Camurus AB, Grunenthal, Ethypharm, Molteni Farmaceutici, Lacer and Asofarma
Spain Adult Malignant Glioma Therapeutics Market Analysis
The Spain Adult Glioma Therapeutics Market is valued at around $42 Mn in 2022 and is projected to reach $78 Mn by 2030, exhibiting a CAGR of 7.9% during the forecast period. The market growth is driven by increased healthcare spending by the government, increasing needs due to aging population and thus increased prevalence of the disease. Key players in the Spain Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Celyad, AbbVie, CureVac, Celyad, Vaxxilon, Oncolytics Biotech, Elekta, Varian Medical Systems etc.
Spain Sleep Disorders Market Analysis
This report presents a strategic analysis of the Spain Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Spain Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Spain Radiotherapy Market Analysis
By 2030, it is anticipated that the Spain Radiotherapy Market will reach a value of $197 Mn from $133 Mn in 2022, growing at a CAGR of 5% during 2022-2030. The Radiotherapy Therapeutics Market in Spain is dominated by a few domestic players such as IBA Dosimetry Iberia, Oncovision, and Elekta Iberia. The radiotherapy market in Spain is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Spain Radiotherapy is increasing on account of the rise in cancer cases in the country.
Spain Oncology Therapeutics Market Analysis
By 2030, the Spain Oncology Therapeutics Market is anticipated to reach a value of $6.2 Bn from $3.5 Bn in 2022, growing at a CAGR of 7.4% during 2022-30. The Oncology Therapeutics Market in Spain is dominated by a few domestic pharmaceutical companies such as PharmaMar, Grifols, and Oryzon Genomics. The Oncology Therapeutics Market in Spain is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Spain Oncology Therapeutics is increasing due to the rise in initiatives taken by the country's government.
Spain Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Spain Liver Cancer Therapeutics market will reach a value of $193.2 Mn from $56.5 Mn in 2022, growing at a CAGR of 16.6% during 2022-30. Liver Cancer Therapeutics in Spain is dominated by a few domestic pharmaceutical companies such as OncoMark, Grifols, and PharmaMar. The Liver Cancer Therapeutics market in Spain is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Spain Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Spain Healthcare Insurance Market Analysis
Spain's healthcare insurance market is projected to grow from $39.11 Bn in 2022 to $65.21 Bn by 2030, registering a CAGR of 6.6% during the forecast period of 2022-30. The main factors driving the growth would be increasing healthcare costs, government initiatives, lifestyle changes, and an aging population. The market is segmented by the component, provider, coverage, health insurance plans, and end-user. Some of the major players include VidaCaixa, Mapfre, Mutua Madrilena, Generali, and Allianz.
Spain Healthcare Financial Analytics Market Analysis
Spain Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a CAGR of 5.8% from 2022-30 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Spain’s Healthcare Financial Analytics market will grow as the demand for data-driven decision-making is rising, and financial analytics. The key market players are Salumedia Tecnologías, Datadec, Dicompacs, Biocryptology, Health in Code, and others.
Spain ENT Devices Market Analysis
Spain's ENT Devices Market is projected to grow from $450 Mn in 2022 to $650 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022 -30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Spain ENT devices market include Interacoustics, Facoelche, and Schuco.